Assessing Splanchnic Compartment Using Portal Venous Doppler and Impact of Adding It to the EVEREST Score for Risk Assessment in Heart Failure

BACKGROUND: The Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) score has proven useful for risk prediction in acute decompensated heart failure (ADHF). However, this score does not include the characterization of the splanchnic compartment, which has been...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:CJC Open
Autors principals: Bouabdallaoui, Nadia, Beaubien-Souligny, William, Oussaïd, Essaïd, Henri, Christine, Racine, Normand, Denault, André Y., Rouleau, Jean L.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7499287/
https://ncbi.nlm.nih.gov/pubmed/32995715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cjco.2020.03.012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars